Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/202884
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis

AuthorsBossini-Castillo, L.; Campillo-Davó, D.; López-Isac, Elena; Carmona, F. D.; Simeón, Carmen P.; Carreira, P.; Callejas-Rubio, J. L.; Castellví, I.; Fernández-Nebro, A.; Rodríguez-Rodríguez, Luis; Rubio-Rivas, M.; García-Hernández, F.J.; Madroñero, A.B.; Beretta, L.; Santaniello, Alessandro; Lunardi, C.; Airó, Paolo; Hoffmann-Vold, A. M.; Kreuter, A.; Riemekasten, G.; Witte, Torsten; Hunzelmann, Nicolas; Vonk, Madelon C.; Voskuyl, Alexandre E.; de Vries-Bouwstra, Jeska; Shiels, Paul G.; Herrick, A.; Worthington, J.; Radstake, T. R.; Martín, J.; Spanish Scleroderma Group
KeywordsMIF
PULMONARY ARTERIAL HYPERTENSION
SYSTEMIC SCLEROSIS
rs755622
Issue DateJul-2017
PublisherJournal of Rheumatology Publishing Company
CitationJournal of Rheumatology
AbstractOBJECTIVE: Systemic sclerosis (SSc) is a fibrotic immune-mediated disease of unknown etiology. Among its clinical manifestations, pulmonary involvement is the leading cause of mortality in patients with SSc. However, the genetic factors involved in lung complication are not well defined. We aimed to review the association of the MIF gene, which encodes a cytokine implicated in idiopathic pulmonary hypertension among other diseases, with the susceptibility and clinical expression of SSc, in addition to testing the association of this polymorphism with SSc-related pulmonary involvement. METHODS: A total of 4392 patients with SSc and 16,591 unaffected controls from 6 cohorts of European origin were genotyped for the MIF promoter variant rs755622. An inverse variance method was used to metaanalyze the data. RESULTS: A statistically significant increase of the MIF rs755622*C allele frequency compared with controls was observed in the subgroups of patients with diffuse cutaneous SSc (dcSSc) and with pulmonary arterial hypertension (PAH) independently (dcSSc: p = 3.20E-2, OR 1.13; PAH: p = 2.19E-02, OR 1.32). However, our data revealed a stronger effect size with the subset of patients with SSc showing both clinical manifestations (dcSSc with PAH: p = 6.91E-3, OR 2.05). CONCLUSION: We reviewed the association of the MIF rs755622*C allele with SSc and described a phenotype-specific association of this variant with the susceptibility to develop PAH in patients with dcSSc.
URIhttp://hdl.handle.net/10261/202884
DOI10.3899/jrheum.161369
ISSN0315-162x
E-ISSN1499-2752
Appears in Collections:(IPBLN) Artículos

Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,35 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

6
checked on Nov 23, 2021

SCOPUSTM   
Citations

20
checked on Nov 30, 2021

WEB OF SCIENCETM
Citations

16
checked on Dec 1, 2021

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.